QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
NASDAQ:SRGA

Surgalign - SRGA Stock Forecast, Price & News

$2.12
+0.08 (+3.92%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.87
$2.19
50-Day Range
$1.36
$2.79
52-Week Range
$1.34
$21.45
Volume
79,373 shs
Average Volume
60,787 shs
Market Capitalization
$14.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$30.00

Surgalign MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,315.1% Upside
$30.00 Price Target
Short Interest
Healthy
1.91% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.44mentions of Surgalign in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($3.66) to ($0.98) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.94 out of 5 stars

Medical Sector

728th out of 1,055 stocks

Surgical Appliances & Supplies Industry

15th out of 24 stocks


SRGA stock logo

About Surgalign (NASDAQ:SRGA) Stock

Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. Its products portfolio include cervical fixation, The Streamline (TL) fixation, motion preservation, orthobiologics, cervical inter-body fusion, TL IBF, and SI joint fusion. It offers coflex interlaminar stabilization device, SImmetry sacroiliac joint fusion system, and Fortilink IBF system with TETRAfuse?3D technology. The company was founded on February 12, 1998 and is headquartered in Deerfield, IL.

Receive SRGA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgalign and its competitors with MarketBeat's FREE daily newsletter.

SRGA Stock News Headlines

The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
Surgalign Holdings, Inc. (NASDAQ: SRGA)
See More Headlines
Receive SRGA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgalign and its competitors with MarketBeat's FREE daily newsletter.

SRGA Company Calendar

Last Earnings
11/02/2022
Today
1/27/2023
Next Earnings (Estimated)
3/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SRGA
Employees
231
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$30.00
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$30.00
Forecasted Upside/Downside
+1,315.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-84,650,000.00
Pretax Margin
-124.83%

Debt

Sales & Book Value

Annual Sales
$90.50 million
Book Value
$1.69 per share

Miscellaneous

Free Float
6,060,000
Market Cap
$14.32 million
Optionable
Optionable
Beta
1.76

Key Executives

  • Terry M. RichTerry M. Rich
    President, Chief Executive Officer & Director
  • David B. Lyle
    Chief Financial Officer
  • G. Bryan Cornwall
    Executive VP-Research & Clinical Affairs
  • Bob Watkins
    Chief Technology Officer
  • Kris Siemionow
    Chief Medical Officer













SRGA Stock - Frequently Asked Questions

Should I buy or sell Surgalign stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgalign in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" SRGA shares.
View SRGA analyst ratings
or view top-rated stocks.

What is Surgalign's stock price forecast for 2023?

1 Wall Street research analysts have issued 1-year price objectives for Surgalign's shares. Their SRGA share price forecasts range from $30.00 to $30.00. On average, they anticipate the company's stock price to reach $30.00 in the next year. This suggests a possible upside of 1,315.1% from the stock's current price.
View analysts price targets for SRGA
or view top-rated stocks among Wall Street analysts.

How have SRGA shares performed in 2023?

Surgalign's stock was trading at $1.99 on January 1st, 2023. Since then, SRGA shares have increased by 6.5% and is now trading at $2.12.
View the best growth stocks for 2023 here
.

Are investors shorting Surgalign?

Surgalign saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 110,600 shares, an increase of 15.9% from the December 31st total of 95,400 shares. Based on an average daily volume of 73,700 shares, the short-interest ratio is presently 1.5 days. Currently, 1.9% of the company's shares are short sold.
View Surgalign's Short Interest
.

When is Surgalign's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 21st 2023.
View our SRGA earnings forecast
.

How were Surgalign's earnings last quarter?

Surgalign Holdings, Inc. (NASDAQ:SRGA) posted its earnings results on Wednesday, November, 2nd. The company reported ($1.96) earnings per share for the quarter. The firm had revenue of $20.18 million for the quarter. Surgalign had a negative net margin of 73.11% and a negative trailing twelve-month return on equity of 343.08%.

When did Surgalign's stock split?

Shares of Surgalign reverse split before market open on Tuesday, May 17th 2022. The 1-30 reverse split was announced on Tuesday, May 17th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 17th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What guidance has Surgalign issued on next quarter's earnings?

Surgalign updated its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $82.00 million-$84.00 million, compared to the consensus revenue estimate of $85.96 million.

What is Surgalign's stock symbol?

Surgalign trades on the NASDAQ under the ticker symbol "SRGA."

How do I buy shares of Surgalign?

Shares of SRGA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Surgalign's stock price today?

One share of SRGA stock can currently be purchased for approximately $2.12.

How much money does Surgalign make?

Surgalign (NASDAQ:SRGA) has a market capitalization of $14.32 million and generates $90.50 million in revenue each year. The company earns $-84,650,000.00 in net income (profit) each year or ($12.2299) on an earnings per share basis.

How many employees does Surgalign have?

The company employs 231 workers across the globe.

How can I contact Surgalign?

Surgalign's mailing address is 520 LAKE COOK ROAD SUITE 315, DEERFIELD IL, 60015. The official website for the company is www.surgalign.com. The company can be reached via phone at (224) 303-4651, via email at info@surgalign.com, or via fax at 386-418-0342.

This page (NASDAQ:SRGA) was last updated on 1/27/2023 by MarketBeat.com Staff